Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Léonie Archambault, Marie-Ève Goyer, Judith Sabetti & Michel Perreault. (2023) Implementing injectable opioid agonist treatment: a survey of professionals in the field of opioid use disorders. Drugs: Education, Prevention and Policy 30:4, pages 434-442.
Read now
Read now
Stephanie K. Rubel, Matthew Eisenstat, Jessica Wolff, Michael Calevski & Sasha Mital. (2023) Scope of, Motivations for, and Outcomes Associated with Buprenorphine Diversion in the United States: A Scoping Review. Substance Use & Misuse 58:5, pages 685-697.
Read now
Read now
Yue Liu, Nina Liu, Wenwen Shen, Longhui Li, Wenhua Zhou & Leiting Xu. (2021) The Abuse Characteristics of Amphetamine-Type Stimulants in Patients Receiving Methadone Maintenance Treatment and Buprenorphine Maintenance Treatment. Drug Design, Development and Therapy 15, pages 2109-2116.
Read now
Read now
Articles from other publishers (21)
Aaron R. Brown, Jayme E. Walters, Beth Harmer, Lara Cates & Aubrey E. Jones. (2023) Non-prescribing clinicians' treatment orientations and attitudes toward treatments for opioid use disorder: Rural differences. Journal of Substance Use and Addiction Treatment 155, pages 209153.
Crossref
Crossref
Raagini Jawa, Yjuliana Tin, Samantha Nall, Susan L. Calcaterra, Alexandra Savinkina, Laura R. Marks, Simeon D. Kimmel, Benjamin P. Linas & Joshua A. Barocas. (2023) Estimated Clinical Outcomes and Cost-effectiveness Associated With Provision of Addiction Treatment in US Primary Care Clinics. JAMA Network Open 6:4, pages e237888.
Crossref
Crossref
Leslie D. Williams, Eunhye Lee, Kathleen Kristensen, Mary Ellen Mackesy-Amiti & Basmattee Boodram. (2023) Community-, network-, and individual-level predictors of uptake of medication for opioid use disorder among young people who inject drugs and their networks: A multilevel analysis. Drug and Alcohol Dependence 244, pages 109782.
Crossref
Crossref
Ayako W Fujita, Aditi Ramakrishnan, C Christina Mehta, Oyindamola B Yusuf, Tracey Wilson, Steven Shoptaw, Adam W Carrico, Adaora A Adimora, Ellen Eaton, Mardge H Cohen, Jennifer Cohen, Adebola Adedimeji, Michael Plankey, Deborah Jones, Aruna Chandran, Jonathan A Colasanti & Anandi N Sheth. (2023) Substance Use Treatment Utilization Among Women With and Without Human Immunodeficiency Virus. Open Forum Infectious Diseases 10:1.
Crossref
Crossref
Hannah R. Tierney, Christopher L. Rowe, Diana A. Coffa, Shashi Sarnaik, Phillip O. Coffin & Hannah R. Snyder. (2022) Inpatient Opioid Use Disorder Treatment by Generalists is Associated With Linkage to Opioid Treatment Programs After Discharge. Journal of Addiction Medicine 16:2, pages 169-176.
Crossref
Crossref
Phillip L. Marotta, Bilal T. Abbas, Kristi Stringer, Diane Huang, Jakob Schnaidt, Dawn Goddard-Eckrich, Nabila El-Bassel & Louisa Gilbert. (2021) Socio-ecological and pharmacy-level factors associated with buprenorphine stocking at pharmacies in New York City. International Journal of Drug Policy 97, pages 103321.
Crossref
Crossref
Elisabeth Poorman, Sara N. Glick, Jonathan K.D. Hiser, Elenore Bhatraju & Judith I. Tsui. (2021) Increased utilization of buprenorphine and methadone in 2018 compared to 2015 among Seattle-area persons who inject drugs. Journal of Substance Abuse Treatment 129, pages 108375.
Crossref
Crossref
Sandeep M. Nayak, Andrew S. Huhn, Cecilia L. Bergeria, Eric C. Strain & Kelly E. Dunn. (2021) Familial perceptions of appropriate treatment types and goals for a family member who has opioid use disorder. Drug and Alcohol Dependence 221, pages 108649.
Crossref
Crossref
Judith I. Tsui, Mary A. Akosile, Gwen T. Lapham, Denise M. Boudreau, Eric A. Johnson, Jennifer F. Bobb, Ingrid A. Binswanger, Bobbi Jo H. Yarborough, Joseph E. Glass, Rebecca C. Rossom, Mark T. Murphy, Chinazo O. Cunningham, Julia H. Arnsten, Manu Thakral, Andrew J. Saxon, Joseph O. Merrill, Jeffrey H. Samet, Gavin B. Bart, Cynthia I. Campbell, Amy M. Loree, Angela Silva, Angela L. Stotts, Brian Ahmedani, Jordan M Braciszewski, Rulin C. Hechter, Thomas F. Northrup, Viviana E. Horigian & Katharine A. Bradley. (2021) Prevalence and Medication Treatment of Opioid Use Disorder Among Primary Care Patients with Hepatitis C and HIV. Journal of General Internal Medicine 36:4, pages 930-937.
Crossref
Crossref
Sara N. Glick, Kathryn S. Klein, Joe Tinsley & Matthew R. Golden. (2020) Increasing Heroin‐Methamphetamine (Goofball) Use and Related Morbidity Among Seattle Area People Who Inject Drugs. The American Journal on Addictions 30:2, pages 183-191.
Crossref
Crossref
Joshua A Barocas, Jake R Morgan, Jianing Wang, Dylan McLoone, Alysse Wurcel & Michael D Stein. (2021) Outcomes Associated With Medications for Opioid Use Disorder Among Persons Hospitalized for Infective Endocarditis. Clinical Infectious Diseases 72:3, pages 472-478.
Crossref
Crossref
Theddeus Iheanacho, Tanner Bommersbach, Brian Fuehrlein, Bachaar Arnaout & Charles Dike. (2020) Brief Training on Medication-Assisted Treatment Improves Community Mental Health Clinicians’ Confidence and Readiness to Address Substance Use Disorders. Community Mental Health Journal 56:8, pages 1429-1435.
Crossref
Crossref
Rashunda Lewis, Amy R Baugher, Teresa Finlayson, Cyprian Wejnert, Catlainn Sionean, Pascale Wortley, Jeff Todd, David Melton, Colin Flynn, Danielle German, Monina Klevens, Rose Doherty, Conall O’Cleirigh, Antonio D Jimenez, Thomas Clyde, Jonathon Poe, Margaret Vaaler, Jie Deng, Alia Al-Tayyib, Daniel Shodell, Emily Higgins, Vivian Griffin, Corrine Sanger, Salma Khuwaja, Zaida Lopez, Paige Padgett, Ekow Kwa Sey, Yingbo Ma, Hugo Santacruz, Meredith Brantley, Christopher Mathews, Jack Marr, Emma Spencer, Willie Nixon, David Forrest, Bridget Anderson, Ashley Tate, Meaghan Abrego, William T Robinson, Narquis Barak, Jeremy M Beckford, Sarah Braunstein, Alexis Rivera, Sidney Carrillo, Abdel R Ibrahim, Afework Wogayehu, Louis Moraga, Kathleen A Brady, Jennifer Shinefeld, Chrysanthus Nnumolu, Timothy W Menza, E Roberto Orellana, Amisha Bhattari, Anna Flynn, Onika Chambers, Marisa Ramos, Willi McFarland, Jessica Lin, Desmond Miller, Sandra Miranda De León, Yadira Rolón-Colón, María Pabón Martínez, Tom Jaenicke, Sara Glick, Jennifer Kienzle, Brandie Smith, Toyah Reid, Jenevieve Opoku & Irene Kuo. (2020) Healthcare Access and Utilization Among Persons Who Inject Drugs in Medicaid Expansion and Nonexpansion States: 22 United States Cities, 2018. The Journal of Infectious Diseases 222:Supplement_5, pages S420-S428.
Crossref
Crossref
Honora Englander, Caroline King, Christina Nicolaidis, Devin Collins, Alisa Patten, Jessica Gregg & P. Todd Korthuis. (2020) Predictors of Opioid and Alcohol Pharmacotherapy Initiation at Hospital Discharge Among Patients Seen by an Inpatient Addiction Consult Service. Journal of Addiction Medicine 14:5, pages 415-422.
Crossref
Crossref
Jacqueline E. Goldman, Elizabeth A. Samuels, Josiah D. Rich & Brandon D.L. Marshall. (2020) Correlates of death during outpatient treatment for opioid use disorder: A national study. Journal of Substance Abuse Treatment 112, pages 76-85.
Crossref
Crossref
Joseph H. Donroe, Elenore P. Bhatraju, Judith I. Tsui & E. Jennifer Edelman. (2020) Identification and Management of Opioid Use Disorder in Primary Care: an Update. Current Psychiatry Reports 22:5.
Crossref
Crossref
Samantha Colledge, Amy Peacock, Janni Leung, Sarah Larney, Jason Grebely, Matthew Hickman, Evan Cunningham, Adam Trickey, Jack Stone, Peter Vickerman & Louisa Degenhardt. (2019) The prevalence of non-fatal overdose among people who inject drugs: A multi-stage systematic review and meta-analysis. International Journal of Drug Policy 73, pages 172-184.
Crossref
Crossref
Caroline A. Browne & Irwin Lucki. (2019) Targeting opioid dysregulation in depression for the development of novel therapeutics. Pharmacology & Therapeutics 201, pages 51-76.
Crossref
Crossref
Terhi N. Keltanen, Pertti K. Heikman, Leea H. Muhonen, Teemu O. Gunnar & Ilkka A. Ojanperä. (2019) Enzymatic assay for urine lactose in the assessment of recent intravenous abuse of buprenorphine. Drug Testing and Analysis 11:9, pages 1412-1418.
Crossref
Crossref
Bjorn E. Payne, Jared W. Klein, Claire B. Simon, Jocelyn R. James, Sara L. Jackson, Joseph O. Merrill, Rui Zhuang & Judith I. Tsui. (2019) Effect of lowering initiation thresholds in a primary care-based buprenorphine treatment program. Drug and Alcohol Dependence 200, pages 71-77.
Crossref
Crossref
Stephanie K. Rubel, Matthew Eisenstat, Jessica Wolff, Michael Calevski & Sasha Mital. (2022) Scope of, Motivations for, And Outcomes of Diverted Buprenorphine Among People Using Buprenorphine: A Scoping Review. SSRN Electronic Journal.
Crossref
Crossref